medigraphic.com
ISSN 1561-3062 (Electronic)

2014, Number 2

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2014; 40 (2)

Characterization of postpartum uterine bleeding patients where misoprostol was used

Lugo SAM

Language: Spanish
References: 19
Page: 145-154
PDF size: 74.74 Kb.


ABSTRACT

Introduction: puerperal uterine bleeding or postpartum hemorrhage is the leading cause of maternal mortality in poor countries.
Objective: this paper aims to characterize patients with immediate PPH and the use of misoprostol in them.
Methods: a descriptive, longitudinal, retrospective study was conducted in patients who had immediate postpartum hemorrhage, and who did not respond to ergometrine or oxytocin at the Gynecobstetric Teaching Hospital in Guanabacoa from January to December 2011. 37 medical records of patients who had uterine atony were evaluated; 32 of them were selected (sample) who reported this event in the first 4 h postpartum.
Results: the study found that out of 32 women, 53 % were multiparous, 30 % of patients with immediate PPH were 37 and 42 weeks gestational age and 22 of them had normal vaginal delivery. Prolonged latent phase was nots ignificantly.
Conclusions: misoprostol is recommended to be used during the immediate postpartum hemorrhage due to its verified effectiveness.


REFERENCES

  1. González MJ, González BJ, González BE. Puerperio y lactancia. En: Ginecología I. 5ta ed. España: Editorial Elsevier, 2006. p. 349-52.

  2. Rosen P, Marx J, Stein R, Hockbe t, Walls RM. Medicina de Urgencias. España: Editorial Elsevier; 2010.

  3. Cabezas E. Mortalidad materna, un problema por resolver. Rev Cubana Obstet Ginecol [serie en Internet]. 2009 [citado 12 Feb 2010];35(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 600X2009000300001&lng=es

  4. Breathnach F, Geary M. Uterine atony: definition, prevention, nonsurgical management, and uterine tampon de Semin. Perinatol. 2009;33(2):82-7.

  5. Duke, J. Serie Secretos: Anestesia. 3ra. ed. España: Editorial Elsevier; 2006.

  6. Pérez L, Fustino R. Postpartum hemorrhage PPH and the B-Lynch technique. Gineweb, University of Zaragoza [Internet]. 2009. [citado 12 Feb 2010]. Disponible en: http://www.unizar.es/gine/B-Lynch.htm

  7. Anderson JM, Etches DM. Prevention and management of postpartum hemorrhage. American Family Physician. 2007;75(6):875-82.

  8. Sociedad Española de Ginecología y Obstetricia. Fundamentos de Obstetricia. España: Editorial Elsevier; 2009.

  9. Botero UJ, Alfonso JH, Guillermo H. Obstetricia y Ginecología. 7ma. ed. Corporación para Investigaciones Biológicas [Internet]. 2008 [citado 5 Jun 2010]. Disponible en: http://books.google.es/books?id=opXDMTRnzFAC

  10. Gómez NY, Nápoles MD, Caveda GAE, Couto ND. Utilización del misoprostol como método preinductivo del trabajo de parto. MEDISAN [serie en Internet]. 2008 [citado 12 Abr 2011];12(3):[aprox 5 p.]. Disponible en: http://bvs.sld.cu/revistas/san/vol12_3_08/san02308.htm

  11. Carmenate ML, Coranado MR, Hernández RJ, Sánchez TJ. Reacciones adversas del misoprostol por vía vaginal en el aborto farmacológico. Mediciego [serie en Internet]. 2010 [citado 22 Feb 2011];16(1):[aprox 5 p.]. Disponible en: http://bvs.sld.cu/revistas/mciego/vol16_01_10/articulos/t-8.htmL

  12. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev. 2007;12(1):71-6.

  13. Caliskan E, Dilbaz B, Meydanli MM, Ozturk N, Narin MA, Haberal A. Oral Misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol. 2008;101(5):921-8.

  14. Oleen MA, Mariano JP. Controlling refractory atonic postpartum haemorrhage with Hemabate sterile solution. Am J Obstet Gynecol. 2009 Jan;162(1):205-8.

  15. Guía Clínica Basada en las Evidencias: Manejo de la Hemorragia Postparto. Centro Latinoamericano de Perinatología y Desarrollo Humano (CLAP) Novedades del CLAP. 2008;16:45-9.

  16. Vázquez Cabrera J. Hemorragias posteriores al parto. En: Embarazo, parto y puerperio. Principales complicaciones. La Habana: ECIMED; 2009. p. 71-89.

  17. Arce HRM, Calderón CE, Cruz C P, Díaz VM, Medécigo MF, Consuelo A, et al. Hemorragia obstétrica en la segunda mitad del embarazo. Revista Médica del IMSS [serie en Internet]. 2012 [citado 16 May 2011];50(6):[aprox 5 p.]: Disponible en: http://www.ebscohost.com/ehost/resultsadvanced?sid=f40251a6-a442-49f7-9721

  18. Gülmezoglu AM, Villar J, Nhy NN, Piaggio G, Carroli G, Adetoro L, et al. Multicentre randomized trial of misoprostol in the management of the third stage of labour. The Lancet. 2010;358:689-95.

  19. Angarita W, Rodríguez B, Borré O. Prevención de la hemorragia poscesárea con misoprostol sublingual vs. oxitocina. Estudio presentado en el XXII Congreso Colombiano de Ginecología y Obstetricia. Cartagena 2000. Publicado en Libro Premio AFIDRO a la investigación médica 2000. Cnt Obst Ginecol 2000;6:57-61.




2020     |     www.medigraphic.com